x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:19:09

After switching to a new GalNAc-LNP delivery vehicle...

BiotechTV - News ·

2025/04/14

Co-Founder & CEO Sek Kathiresan walks us through the data, which so far has showed a clean safety profile and an impressive ability to lower LDL by over 50% in patients with a genetic form of hypercholesterolemia.

en-us

00:11:41

Mount Sinai has embraced AI as a drug discovery tool...

BiotechTV - News ·

2025/04/10

Dr. Schlessinger descrbies how the new center is meant to speed up drug discovery work and enable Mount Sinai researchers to develop molecules that are more dynamic and with a higher success rate. It might also enable them to take drug development further than they traditionally have before.

en-us

00:14:30

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/10

They discusses takeaways from the conference, and comment on Beam, Korro, Wave, Intellia, Prime, Janux, Alto Nuero, Rapport, and YmAbs.

en-us

00:07:37

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/10

CFO David Nassif describes the unmet need that still exists today in HAE, and updates us on programs in both the acute and prophylactic settings.

en-us

00:13:47

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/10

He describes where this fits into the ROS1 space, and the data that has been derived for the filing. Plus, mIDH1, drug-drug-conjugates, and his take on the current environment in biotech.

en-us

00:15:27

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

He describes the 48 week data for the exon 53 DMD program, and discusses the company's plan to seek accelerated approval. Plus, guidance on when to expect clinical updates on other programs.

en-us

00:15:52

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

Brad Sitko describes how XOMA is able to do smaller deals than other larger investors in this space, and he gives examples of investments they have made. Plus how to help with the "zombie biotech" problem in some corners of the sector.

en-us

00:11:14

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

She describes how the mechanism of Haduvio differs from other programs in chronic cough, and covers the recent phase 2a RIVER data.

en-us

00:10:25

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

They discusses the macro and regulatory factors that have affected the sector so strongly, and comment on Wave, Korro, ProQr, Capricor, Trevi, and Kalvista.

en-us

00:16:02

Analyst Thursdays: Stifel's Alex Thompson updates us...

BiotechTV - News ·

2025/04/03

He shares his take on biotech and discusses argenx, Immunovant, AnaptysBio, Apogee, Dianthus, and Viridian.

en-us

00:05:21

Anglo Nordic Life Science Conference: The CEO of Cure...

BiotechTV - News ·

2025/04/03

CEO Helen Matthews describes the types of medicines they are supporting for clinical trials (including Ambroxol and GLP-1s), and folding a few programs into a dynamic, international consortium.

en-us

00:08:56

Anglo Nordic Life Science Conference: Denmark based...

BiotechTV - News ·

2025/04/03

Co-Founder and CEO Thomas Kledal describes the science behind this platform and program. Plus, how having access to donated kidneys is helping the company with its translational work.

en-us

00:12:59

On the heels of raising a $65M series B, the CEO of...

BiotechTV - News ·

2025/04/03

CEO Jason Gardner describes Ampersand's platform that is designed to make medicines act at the site of disease. He also shares updates on partnerships with Pfizer and Pioneering Medicines, and highlights work in obesity, immuno-inflammation and immuno-oncology.

en-us

00:10:41

BioTrinity 2025: With a novel E3 ubiquitin ligase...

BiotechTV - News ·

2025/04/02

CEO Nicki Thompson describes why she believes the company is differentied in the field, and how TRIMTECH's construct is designed to selectively degrade aggregates that cause neurodegeneration.

en-us

00:10:00

Vida Ventures named Matt Cohen and Brian Goodman new...

BiotechTV - News ·

2025/04/02

He describes his background in life sciences investing and shares his take on the current state of the sector.

en-us

00:14:06

After a $93M series B, Character Bio's CEO Cheng...

BiotechTV - News ·

2025/04/02

He describes why a 'one-size-fits-all' approach has caused numerous ophthalmology trials to fail in the past, and why Character believes a precision medicine approach is overdue.

en-us

00:12:07

BioTrinity 2025: AlveoGene Executive Chair David...

BiotechTV - News ·

2025/04/01

He describes the science behind the platform, which is already being used by Boehringer Ingelheim for cystic fibrosis. AlveoGene has plans to use it for conditions like the surfactant protein deficiencies SP-B & ABCA3, alpha-1 antitrypsin deficiency, and IPF.

en-us

00:14:06

Miami based Galatea Bio raised $25M today to expand...

BiotechTV - News ·

2025/03/27

Founder and CEO Carlos Bustamante tells BiotechTV's AI Correspondent, Ryan Flinn, about the biobank and why it is important to better understand how diseases can have different profiles across diverse populations. Plus, how AI will play a role in this work.

en-us

00:11:00

State of Possible: Winner of the MassBioDrive Startup...

BiotechTV - News ·

2025/03/27

Mari Anne Snow describes the advantages she sees nanoparticles having over current modalities like viral vectors, LNPs, and others.

en-us

00:04:02

State of Possible: Atlas Venture's Bruce Booth shares...

BiotechTV - News ·

2025/03/26

He describes the 14th fund that Atlas raised at the end of last year, which was $450 million. Plus, his take on the environment, regulatory changes, China's impact on the sector, and improving biopharma's image.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter